Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

S1 2020 Earnings Call
Company Participants
FINAL

Amanda Blanc, Chief Executive Officer
Jason Windsor, Chief Financial Officer

Other Participants
Abid Hussain, Analyst
Andrew Crean, Analyst
Ashik Musaddi, Analyst
Blair Stewart, Analyst
Colm Kelly, Analyst
Dominic O'Mahony, Analyst
Fahad Changazi, Analyst
Gordon Aitken, Analyst
Greig Paterson, Analyst
James Shuck, Analyst
Jonathan Hocking, Analyst

Bloomberg Transcript

Oliver Steel, Analyst

Presentation
Operator
Good morning, and welcome to Aviva plc's Half Year 2020 Financial Results Briefing.
I would now hand you over to your call host, Amanda Blanc, CEO of Aviva Plc.

Amanda Blanc

{BIO 19138679 <GO>}

Thanks, Nicole; and good morning, everyone. Thank you for joining us and welcome to our
conference call to take you through our interim results.
This is obviously the first occasion that I have had the opportunity to speak to you, so I will
make some introductory remarks, and then I'll ask Jason to take you through the results.
The slides are available on our website and our intention is not to go through each slides.

Page 1 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

Let me start by saying that I have become Chief Executive of Aviva at an extraordinary
time. The COVID crisis has been a tragedy for so many and Aviva's response has been
spot on, whether that would be the smooth running of our business, the GBP43 million we
have donated to support charities and communities; or how our people have looked after
our customers. I couldn't have asked for more and am incredibly proud of the hard work
of all our people. I think it is important to recognize this, first and foremost.
Now, if I may, I would like to turn to strategy. When I was appointed Chief Executive just
four weeks ago, I said I would work at pace to assess our strategic opportunities and the
actions that we should take across our portfolio. That is exactly what I have been doing
and, today, I would like to give you a clear statement of my priorities and our future
direction of travel.
Let me start by saying that Aviva have enormous potential. We have fantastic franchises,
market leading capabilities, trusted long-term relationships with both customers and
distributors, and, above all, we have great people. However, it is already abundantly clear
to me that to unlock this potential, meaningful change is required. That is the challenge
and that is exactly what I intend to deliver.

Bloomberg Transcript

To achieve this, I have three priorities. First, we will focus the portfolio. We will concentrate
Aviva around our strongest businesses in the UK, Ireland and Canada with the aim of
being the UK's leading insurer. We are a top three player in each of these market with
attractive earnings growth and return potential. We have a strong powerful brand. We
deliver incredible customer service and, in my view, have a clear path to win. Across these
market, we will invest for growth.
In our international businesses in Europe and Asia, our approach will be to manage for
long-term shareholder value. We will be selective about where we participate and we will
allocate capital with discipline. If we see attractive opportunities to be market leader,
generate strong returns, deliver robust cash flows to the center and ultimately win, we will
invest.
But let me be clear, if we cannot meet our strategic objectives, we will take decisive
action and we will withdraw capital. Ultimately, there may be better owners for these
businesses than Aviva in the longer term.
My second priority will be to transform performance. As I said, Aviva has fantastic
businesses and I really mean that. I've been a competitor of Aviva for a large part of my
career, and I can tell you that Aviva has a formidable market position in terms of our
brand, customers, distribution and capabilities in digital and data science, we benchmark
extremely well in these areas.
For example, in our life and GI businesses, TNPS is running in the 40s and 50s across a
number of categories. These are outstanding scores in anyone's book. Once more, they
have been increasing during the COVID lockdown, thanks to the great work of our people
under exceptional circumstances, of which I'm immensely proud.

Page 2 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

Helping our customers during difficult times, it's the reason Aviva exist and it is what we
do best. These scores should tell you that we have a strong foundation in terms of our
customer relationships and that's a great base on which we can build.
If we consider digital, obviously you may think that Aviva has spoken a little less about
digital over the last couple of years. I get that. But the reality is that digital is a critical part
of our future, whether is it insurance or any other sector, customer expectations are
changing and those firms that can offer convenience online, offer true value, and have
trust with their customers, those companies will win a disproportionate market share. That
has been true for some time, but it's even more true post-COVID.
What's interesting is, when you stick back the layers, Aviva has a really great story here.
We've been quietly building up registrations and digital interactions. As a result, logging
for nearly at threefold over two years. Over half of our direct motor and home claims
have submitted online and digital is embedded in our distributor relationships. We are
succeeding at helping customers to access information and transact faster. That gives us
a positive baseline for customer experience and of course efficiency.
Make no mistake though, we are not the finished article and there is a lot that must be
done to bring it all together. But again the foundations are there and we have a real point
of differentiation in the breadth of our product, distribution and the customer bases.

Bloomberg Transcript

So if we have the inherent strengths, and I really think we do, why haven't we converted
them into performance and investor support? The truth is, and that's the honest, we
haven't been as good as we needed to be after execution and that is what will change.
So how are we going to do this? Because we all know talking is the easy bit. We will bring
a new intensity to how we approach performance management and competitiveness. It is
virtually impossible to compete and win If you are in the top quartile on efficiency,
customer experience, pricing and risk management. And that is where we need to be.
Getting there will require some fundamental changes in how we operate. I'm really
focused on this and there'll be more detail on this in our future presentation.
Turning to my third priority, financial strengths. Not only financial strength, but also our
financial resilience and sustainability.
In recent years, we've maintained solid capital ratios and strong central liquidity, despite
the external volatility. We are reporting a solid set of half year results today with capital
surplus of GBP12 billion and operating profit of GBP1.2 billion. The impact of COVID on
general insurance claims, net of reinsurance, was GBP165 million in line with the number
we gave at our Q1 updates in May. Our balance sheet risk have significantly reduced, a
priority given the changing macro environment. And we've made progress in reducing
debt leverage, and I'm committed to taking this further.
The actions we intend to take to focus the portfolio will give us greater financial flexibility.
This will allow us to further enhance our financial resilience and capital sustainability and

Page 3 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

will give us optionality either to invest in our businesses or to return capital to our
shareholders.
Financial strength and active capital management are key priorities for Jason and I. And
they would be at the heart of our strategy going forward. And that brings me to the topic
of dividends. We understand the importance of dividends to our shareholders. With that in
mind, the Board has declared a second interim dividend in respect of the 2019 fiscal year
of GBP0.06 per share. This is consistent with our solid financial position and our resilient
results, but also the Board's cautious stance towards the macro risks as the economy
slowly emerges from the current crisis.
More fundamentally, the Board has decided to take the opportunity to review our longerterm dividend policy in light of our strategic priorities, the future shape of the group, and
our ongoing commitment to debt reduction. We will provide an update to shareholders on
all dividend matters, including the 2019 final dividend in the fourth quarter.
Before I hand you over to Jason, who will take you through the highlights of the half year
results, I would like to reiterate my three priorities. Firstly, we will focus on portfolio,
investing for growth across the UK, Ireland and Canada with the aim of being the UK's
leading insurer. Across international, we will manage for long-term shareholder value and
ultimately there may be better owners to these businesses than Aviva in the longer term.
Secondly, we will transform performance. And, finally, financial strength will be the key
underpin.

Bloomberg Transcript

Jason, over to you.

Jason Windsor

{BIO 17967688 <GO>}

Thanks, Amanda; and good morning everybody. As Amanda said, we provided you with
the slide pack on the website and I won't walk through each slide on the call, but I will
make some page number references.
At the backdrop of COVID-19 in the first half, our results demonstrate the strength and
resilience of our business and financial position. As Amanda just commented, financial
resilience is a priority for us going forward. You'll also see that COVID has impacted our
performance in terms of increased insurance claims, reduced customer activity levels,
capital market volatility and the meaningful contribution to support the community.
But as a company we've responded very well and delivered improved underlying returns.
Our customer teams didn't miss a beat. We took decisive action to maintain service
levels, continuing to support our customers when they needed us most. We have not had
to furlough any Aviva employees and we've been able to support colleagues needing to
balance work and childcare.
Starting on Page 10 of the slide pack, the result highlights include return on equity of 7.1%
with underlying return improving 8.3% before the GI impact of COVID. Operating capital
generation increased 14% for GBP890 million, benefiting from significant derisking actions.
Page 4 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

Operating profit of GBP1.2 billion is down 12% and Solvency II NAV is GBP4.16 per share
and GBP0.07 relative to year-end.

FINAL

Excluding the general insurance COVID-19 impact, our headline results is solid. Group
operating profit would have been broadly consistent with half year '19 with positive trends
in BPA, Savings and Retirement of Canada offset by higher weather costs and lower
profitability in Europe and Aviva Investors.
Given that significance, my commentary will first focus on general insurance claims effects.
In IFRS, we estimate net general insurance claims of GBP165 million from COVID-19, which
is in line with the number we gave you on May 21. The estimated business interruption,
another COVID-19 claims, is primarily in IBNR. It's still early days. The net figure of GBP165
million includes just over GBP200 million of favorable claims experienced in the first half,
owing to the reduction in economic activity. That includes Netherlands for similar effect in
the second half. It also has a GBP34 million alone for prior-year inflation, owing to
expected supply chain disruption.

Bloomberg Transcript

On Slide 11 of the pack, for OCG, the impact from GI claims is GBP258 million. This is
higher than IFRS, because it includes an SCR allowance for uncertainty. As a result,
underlying OCG pre-COVID from GI was just shy of GBP800 million, which is up 17% on
the prior year. But this shows that we've increased capital generation and underlying
returns, despite the disruption. But there is much more still to be done to create
sustainable and resilient business.
Turning to the balance sheet. Our solvency cover ratio increased in the second quarter
and was 194% at 30 June. Solvency II surplus at GBP12 billion, which is GBP0.6 billion lower
compared with the year-end figure. Positive operating capital generation was offset by
GBP1.56 billion of market impacts, primarily related to lower interest rates and credit
spread widening.
In February and March, we took significant actions to reduce our risk and investment
portfolios by hedging equities, credit and interest rates. As a result of these actions, we
significantly increased resilience to market risks, which you can see in this morning's
disclosure. We've enhanced our disclosure by providing you with the movement on
surplus as well as the ratio.
Since liquidity at the end of July was GBP2.5 billion, this benefited from the completion of
the FPIL sale in July, which added GBP0.2 billion.
Remittances from subsidiaries we shall see down in the first half at GBP150 million. We did
not see to remit significant cash from the BUs in the first half, given our desire to maintain
strength in the subsidiaries, life of the economic market and pandemic uncertainty and
also regulatory guidance. We expect remittances to increase significantly in the second
half. But given the first half volatility and prevailing uncertainty, we expect full-year 2020 to
be well below the underlying level in 2019, plus approximately GBP100 million more in
proceeds from announced divestments.

Page 5 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

Focusing now on the investment portfolio on Slide 15, which I know is topical. Overall, our
portfolio is performing well and it has remained resilient in the first phase of the credit
downfall. In terms of corporate credit, we've had no defaults and our observed rating
migration remains low. Only 0.2% of the shareholder portfolio has been downgraded
below investment grade, 4% of our corporate bonds rated A or above have been
downgraded to a lower rating letter. This is up only slightly on the 3% we reported to you
in our May update.
Our commercial mortgage portfolio has also remained resilient but by solid collateral,
although we expect the peak economic stress for borrowers to come.
The LTV of the portfolio has increased slightly to 59%. Loan interest cover remains good
at 2.8 times and the portfolio continue to perform and just 1% of loans in arrears. LTV is
above 100%, but just under 5% of the portfolio and our long-term commercial property
price assumption with a 15% fall over five years. This assumption is an average, which has
not been applied uniformly across the portfolio.

Bloomberg Transcript

As you might expect, in certain areas, by retail, where the pressure is more intense, we've
allowed for much larger declines. And it's worth reminding you we have a GBP3.8 billion
IFRS default reserve across the UK annuities book.
Switching gears and looking at performance and trading on Slide 16. At the group-wide,
our first half sales volumes across life and general insurance overall were broadly flat. In
the context of the disruption we've seen, that's a solid result. We've been very deliberate
in how we've approached new business strategy across the group. As outlined last year,
actively allocating capital was an important part of our strategy. We've announced today
that we will take this further at the strategic level. But from a trading perspective, we're
making choices about where we are prioritizing and you can see the areas where we are
investing for growth and also managing for long-term value.
Looking at some of the individual highlights. In UK Life, BPA volumes were GBP3.1 billion,
an increase of 2.5 times versus the first half of 2019 and approximately 80% of our
volumes in the whole of 2019. This helps us to achieve a net doubling of VNB in UK Life.
In the first half, we had good market conditions for BPA pricing and we were at the higher
volume at an attractive margin. BPA demand remains strong. COVID-19 is not preventing
deals from being completed. We expect BPA volumes to continue to grow in the second
half, but more slowly than in the first half.
In Savings and Retirement, our workplace and retail platforms continue to show good
momentum. Net fund flows increased 28% to positive GBP4.2 billion with good growth in
net flows across workplace and retail savings. Looking at the sequential trends, we saw a
slight reduction in net flows in the second quarter, which was mainly driven by lower
volumes onto the retail platform. However, activity levels improved over the course of Q2.
We're seeing continued strong support from our IFA partners.

Page 6 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

Aviva Investors profitability was pressured by lower revenues from lower asset values and
reduced origination fees. Encouragingly, the third-party franchise make good gains with
positive net flows of GBP1.3 billion in the first half, building on the strong finish to 2019.
In Europe and Asia, new business sales reduced 23%, owing to a combination of COVID19 disruption and our actions to reduce sales and risk profit products in the face of ultralow interest rates. The continued focus on mix helped to increase our new business
margin to 4.2%, up from 3.9% in the prior year. Our own sales networks were able to
adapt well to support customers and write new business. For example, by using digital
tools and video calls. However, our bank distribution partners were constrained by much
lower footfall given the lockdown measures. As Amanda mentioned, we will continue to
be selective in allocating capital to new business in Europe.

Bloomberg Transcript

In general insurance, net written premiums were broadly flat. We saw continued
momentum in commercial lines with growth of 8% and 11% in the UK and Canada,
respectively. Personal lines premium saw a bigger impact in COVID-19, particularly in the
UK where volumes in the intermediary channels were disrupted by lockdowns. The
combined ratio in GI increased 3 percentage points to 99.8%. Excluding the 3.6% impact
from COVID, COR likely compared to the prior year, despite meaningfully higher weather
costs.
Turning to expenses on Slide 18. We've made further progress reducing controllable costs
by GBP54 million. We remain on track to meet our target of GBP300 million reduction by
2022. In the first half, staff costs were lower from actions taken in 2019 and we've
reduced our contracted headcount by more than 50%. While this provided incremental
savings, we had to increase spending in IT to support remote working and we also
contributed GBP43 million to various community support schemes.
At our full year results, we outlined our expectation that 2020 P&L savings will be GBP150
million, which, as a reminder, is on top of absorbing inflation. Based on the first half trend,
we are on track to beat that estimate. We are looking for opportunities to further
accelerate our delivery.
In conclusion, despite the challenges and disruption of COVID-19, we delivered solid
trends in trading profitability and resilient capital. The outlook remains uncertain. We take
some encouragement from the lower number of reported cases, but as recent reports
make clear we are likely to be living with COVID related restrictions for some time to
come. Together with the withdrawal of government support, this will prevent continuing
challenges and delayed any return to normal levels of movement and economic activity.
This makes it inherently difficult to make definitive outlook statements. Broadly, we expect
volume levels for the remainder of 2020 to be around the level in Q2.
Aviva has been deliberately cautious and forward-looking at recent years. We're
continuing to take to a disciplined approach to managing our market and trading risks.
This puts us in a good position to continue to protect and grow value for shareholders
and to embark on our strategic transformation and tremendous leadership.

Page 7 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

Amanda Blanc

{BIO 19138679 <GO>}

FINAL

Thanks, Jason. So, in summary, Aviva is embarking on decisive change that I am confident
will unlock significant value in the business. Focusing on where we have strategic
advantages and scale will give us a clear direction. This focus combined with transforming
our performance and a strong and resilient financial position will put us in the right position
to win and to win for the long term.
I do not intend to disrupt the organization with another lengthy strategic review over
Capital Markets Day. That is not what is required here. I've only been in the seat for a
month, but I'm already confident that we have many of the ingredients to make Aviva a
winner. It is my intention to update the market as we made tangible progress in delivering
on the priorities I have signaled today. I do, of course, look forward to meeting with many
of you virtually or in person in the coming weeks and months and sharing our progress
with you.
But, in the meantime, thank you for listening. And, with that, I'll pass back to the operator
and we will open the lines for questions.

Questions And Answers
Operator

Bloomberg Transcript

Thank you. (Operator Instructions) And your first question comes from the line of Jon
Hocking at Morgan Stanley. Please go ahead. Your line is open.

Q - Jonathan Hocking
Good morning, everybody. I've got three questions, please. Firstly, Amanda, you spoke
about things you'd like to improve operationally in the UK business in particular. Can you
give us some color in terms of where you see the capability gaps? And how those might
some vary by line of business.
Secondly, on the UK business, do you have any thoughts at this stage in terms of where
you'd like to take the business mix?
And then, finally, on the dividends, given the guidance from the various regulatory bodies
in Europe, do you think it's possible to get a dividend from France and Italy in the second
half of the year? Thank you.

A - Amanda Blanc

{BIO 19138679 <GO>}

Okay. Thanks, Jon. I'll pick up the first two of those questions and hand to Jason on the
third. In terms of improving operationally in the UK business and the capability gaps. So I
think as far as the UK business is concerned, we already have a sort of market-leading
position. And the dilemma, I guess, is why does it not turn into a market-leading
performance. And so what we absolutely need to focus on in terms of the performance
of that business is how the investments that we have committed to making -- yes, I think,
Page 8 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

Jason in the Capital Markets Day last November said that it was going to be GBP1.3 billion
over the period. Yes.
How is that investment going to transform into performance? And so what we need to
be, I guess, laser light is the various areas of performance improvement that are required.
So how do we get a better return on capital in some of the business areas that are
currently underperforming. How do we look at what we need to do on expense
efficiency? So we have a quartile in terms of all of our markets at the moment in all of our
segments. We've already started some of that work and we would -- we believe that
there is room to take that further in terms of our customer experience. We've got great
NPS scores, but there will be more we can do to make the customer experience
smoother; pricing, risk management, the list is long, but I think these are all topics. I have
32 years in insurance and we all have a lot of experience around the room. I think we know
where to look.

Bloomberg Transcript

Well, what this is about? It's about execution, right? It's about making sure that we actually
deliver what we say we're going to do and that GBP1.3 billion, the benefits, flow from that.
And that's about rigor and execution, and I believe that that is where we should focus.
And as far as the UK business mix is concerned, look, if I look at the UK and we're number
one in life, we're number one in GI, we sort of got 25% share in workplace market, we are
number two in protection, I think that we are in good shape. We have a good market
position. We have a diversified business and there are huge benefits in that diversification
of our business as I'm sure you know. So I think the business mix looks good. We will be
looking for more growth in terms of the GI business. We know that. But we also know that
there are opportunities in the Savings and Retirement business to see that business grow
and we've already demonstrated in BPA, I think, the solid growths in the last six months.
So maybe, Jason, I hand over to you.

A - Jason Windsor

{BIO 17967688 <GO>}

So the regulatory guidance is evolving and we've seen various statements from multinational agencies and local supervisory agencies. We didn't have -- you mentioned France
and Italy, I think, we didn't have anything penciled in for 2020. I think, as I said, for France
Life we've been seeking to rebuild capital and reset the plans there and Italy is not a
significant dividend for us in any event. Having said that, there are not strict prohibitions.
We continue to get payments back on internal loans and the like. So we've got an
expectation, as I said in the prepared remarks, of significantly higher remittances in the
second half, but less so from some of the international subs.

Q - Jonathan Hocking
Okay. Excellent. Thank you.

Operator
Your next question comes from the line of James Shuck of Citi. Please go ahead. Your line
is open.

Page 9 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

A - Amanda Blanc

{BIO 19138679 <GO>}

Hi, James. You might be on mute.

Q - James Shuck

{BIO 3680082 <GO>}

FINAL

I am indeed on the mute. Apologies for that. Thank you.

A - Amanda Blanc

{BIO 19138679 <GO>}

The most used expression in the lockdown, you might be on the mute.

Q - James Shuck

{BIO 3680082 <GO>}

The things we learned through lockdown. Yeah. I had two questions. So the reduction in
market risk on Solvency II ratio. So big changes there. I guess I'm keen to understand to
what extent that is temporary tactical decision and/or permanent, another implications on
the earnings front, because obviously you are increasing hedging costs and the asset
allocation is changing?

Bloomberg Transcript

And, secondly, on the international operations. You're not explicitly saying disposals, but
you are saying that that might be better ones in the longer term. Are there any
impediments to sale? I know a bunch of the operations, but sell through bancassurance
agreements or through IFA networks. We might have a change of control situation that
might cause problem.
And perhaps you could just update whether there's been any expressions of interest up
to this point? There's been very strategic reviews going on for sometimes, so we just
good to gauge the interest, if there is any? Thank you.

A - Amanda Blanc

{BIO 19138679 <GO>}

Okay. Thank you, James. I'll pick up your second question, and I'll pass over to Jason on
the first. On the international operations and impediments to say, look, I think we're not
saying today that these businesses are disposals, right. So what we're saying is that
they're great businesses, they are excellent people, they serve their customers really
well. And if we see opportunities to expand on that to generate better returns or
sustainable cash flows, we are willing to invest. But if we can't, we do need to be decisive
and withdraw capital. And there may be better owners for the businesses in the longer
term to just repeat, I guess, what I've already said. And you wouldn't expect me to
comment on expressions of interest and I'm not going to do that. And as I said, I'm not
saying that these businesses are disposals.
In terms of impediments for sale and, clearly, we do have strong JV relationships in some
of these markets and we will work through all of that. Jason?

A - Jason Windsor

{BIO 17967688 <GO>}

Sure. I mean, it vary slightly than what we've done. But I would say we have a very clear
economic value framework for asset allocation, where I talked about this at Capital
Page 10 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

Markets Day, where we use the return on economic capital to really drive and define all of
our decisions and that's embedded in the way that we've been thinking about our
balance sheet in the first half. So we're not thinking about risk per se. Capital is not short
in and of itself, but we want to make sure that our exposure to market risks is aligned with
the level of return that we can get.
So on an economic basis, the return is slightly enhanced. In fact there is a small impact on
IFRS as I've talked about before. France was sort of double-digit figure for buying interest
rate swaptions and the interest rates is a risk that isn't really rewarded. So we trying to
make sure that we take them off the table. I don't think there's any significant change to
the reward on the equity and credit side and we've been quite thoughtful about how to
bring that through, mention what we've got in a well-diversified portfolio that the margin
we've been reducing risk, but with wider spreads there to return on an economic basis
has been maintained.

Q - James Shuck

{BIO 3680082 <GO>}

Okay. That's great. Thank you very much.

Operator
Your next question comes from the line of Greig Paterson, KBW. Please go ahead. Your
line is open.

Bloomberg Transcript

Q - Greig Paterson
Good morning, everyone. Can you hear me?

A - Amanda Blanc

{BIO 19138679 <GO>}

Yes. We can hear you.

A - Jason Windsor

{BIO 17967688 <GO>}

Good morning, Greig.

A - Amanda Blanc

{BIO 19138679 <GO>}

Good testing.

Q - Greig Paterson
Hope all are safe and everything. Three questions, please. Just in terms of your internal
mixes, reinsurance mixes, I wonder if you could give us an idea that if those were
removed, how much that would impact the Solvency II ratio?
And the second question is, you mentioned investing in your focus markets. I was
wondering if you would consider -- when I said -- marginal material deals acquisitions in
the UK, Ireland and Canada?

Page 11 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

And the third sort of questions/observation, I note that in the verbiage on the UK Life
there was very little reference to assumption changes/management, actions/optimization
in the annuity, was that because it's now embedded in the underlying, so you're not
calling out separately or it was low this time? And if so, what was the reason? Yeah. Thank
you.

A - Amanda Blanc

{BIO 19138679 <GO>}

Okay. Thank you. I will pick up the second question and Jason will pick up the first and the
third. On the investments in the focus markets, so obviously today is not a day to talk
about acquisition activity, today we're talking about how we want to invest in those
businesses to become market leading performers in the areas that we're in. We already
have actually strong market share positions in all of those markets. So I feel very, very
comfortable about that, but also I'm comfortable that we have some headroom to
continue to grow in those markets. Jason?

A - Jason Windsor

{BIO 17967688 <GO>}

Bloomberg Transcript

Yeah. On the mix to the first order question, the first order answer to your question is
zero. The mixes does not enhance the solvency and by -- we get diversification, it's about
where we see the capital, whether we get it in the group or in the subs and that's
fundamental question. There is a second order subtle point around risk margin there, of
course we won't get into it, but that's a small, very small figure.
On terms of UK Life, the -- on the OCG basis, there was slightly more than on an IFRS
basis that came through where we've had some annuity optimization and activity, the sort
of answer I gave to James a moment ago, we thought hard about how to manage credit
risk in particular as we back the new annuities. But there is no significant one-offs, I would
say, and we certainly haven't changed assumptions and that will be -- we will come to in
the second half.

Q - Greig Paterson
So, Jason, are you saying that if you remove the mix, your diversification credit on the SCR
won't change at all?

A - Jason Windsor

{BIO 17967688 <GO>}

Correct.

Q - Greig Paterson
All right. Thank you. Cheers.

Operator
Your next question comes from the line of Ashik Musaddi at JP Morgan. Please go ahead.
Your line is open.

Page 12 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

Q - Ashik Musaddi

{BIO 15847584 <GO>}

Yeah. Thank you, and good morning, Amanda; good morning, Jason.

A - Amanda Blanc

{BIO 19138679 <GO>}

FINAL

Good morning.

A - Jason Windsor

{BIO 17967688 <GO>}

Good morning.

Q - Ashik Musaddi

{BIO 15847584 <GO>}

Bloomberg Transcript

Just a couple of questions I have is the, first of all, when -- I think you did mention about
the Europe and Asia, that it's not bad businesses, it is just that you are looking for
opportunities, but I mean, what sort of metric shall we look at to decide whether you're
delivering on these businesses or not, whether you want to keep this businesses or not.
What sort of metrics would you focus on, would it be cash, operating profit, OCG? What
will make you decide that these are the businesses you need to keep and these are the
businesses that you don't need to keep? So that could be the first one.
Second thing is, can we get some sense on local solvency ratios to understand how the
remittances are going to look like for second half of this year and how comfortable you
are on the full year remittance for next year? Because clearly, I mean remittances is very
important and given that you are planning that you haven't taken out any remittance in
first half, it will be good to get some color on how we should think about like second half
and next year?
And just last one is, sorry, going back to the dividend topic, I mean you mentioned that
there will be -- there has been a first interim, second interim and there will be a final
dividend. But any color on what should it be based on, should it be based on IFRS
earnings, should it be based on Solvency II capital generation, what metrics do we need
to focus on or should it be based on remittance basis? So any thoughts on that would be
very helpful. Thank you.

A - Amanda Blanc

{BIO 19138679 <GO>}

Okay. Thank you. I'll take the second -- sorry, the first and the third question, and Jason will
take the second.
So on Europe and Asia and the metrics that we will use. So look -- obviously we will look at
this across the range of metrics. I think probably all of the above in terms of the ones that
you mentioned, Ashik, in your point. We will look at the returns of those businesses, we
will look at the sustainability of the cash flows to the center, we will look at the return on
capital, but also we will look at our rights to win and our position within those markets to
see whether or not we actually have the capability to be able to win there recognizing
quite rightly, as you said, that they are good businesses and they are good people in
them and they deliver well for their customers. But it might be that, as we said very clearly,

Page 13 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

there might be better owners in the longer term. But this is part of a sort of a thorough
look that we will take at each of these businesses.
Your point around the dividends and I think we were clear that what we said on the
dividends is that we would come back to all dividend questions in Q4. We felt it was
important to be sort of transparent at this point. But what we will base that dividend policy
on will be the strategic priorities, the (technical difficulty) the portfolio, the ongoing
commitment to debt reduction, and the desire for resilient and a sustainable dividends.
And we felt that as we were making a meaningful change to the strategy, that it was
important that we should also review the dividend. Jason?

A - Jason Windsor

{BIO 17967688 <GO>}

Bloomberg Transcript

Sure. I mean I'll just add on that one. We talked about capital generation and obviously it's
the long-term and we're after the return on capital and as we think about in the long term
clearly we need to turn those returns into cash. So we're trying to manage those two as
the primary metrics, certainly be fed into our thinking as we would doing it for some time.
On the sub solvency ratio, actually all in pretty good shape, having had pretty bumpy first
half to be clear. But I talked at the year-end results about the significantly improved
solvency position in France. I think I said that results, it was up 50 points or so in the
second half and there is no real change. And from that probably backed up a little bit in
July with the falling rates. UK, the big UK subsidiary is down very small single-digit from the
position at year-end. We've worked hard in Solvency. There is an impact in the GI business
as you might imagine pretty much. If you took the COVID-19 loss on OCG basis, the
spread across the GI subsidiaries and you're probably looking about 10 points in those
two subs. That's probably the biggest impact that I could guide with you.

Q - Ashik Musaddi

{BIO 15847584 <GO>}

That's very good. I mean I just have one follow up. Would you be able to comment on the
timeframe that we need to look for Europe and Asia? Like, you are going to give them
one year, two-year or I mean any thoughts on that or is it still too early to give clarity on
that? Thanks.

A - Amanda Blanc

{BIO 19138679 <GO>}

No, I mean, I think, I've been only four weeks in the seat and what we've outlined today is
our framework for how I'm doing the portfolio and we not -- we won't discuss the
timeframe today.

Q - Ashik Musaddi

{BIO 15847584 <GO>}

That's very clear. Thank you.

Operator
Your next question comes from the line of Blair Stewart of Bank of America. Please go
ahead. Your line is open.

Page 14 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

Q - Blair Stewart

{BIO 4191309 <GO>}

FINAL

Thank you very much. Just coming off mute there, almost forgot. A couple of questions.
Firstly on the dividend, I wonder what's the significance of the GBP0.06 that you've
declared today as second and from that it takes us to GBP0.155 dividend payment for full
year '19. Is there any significance at all in that number?
Then just related to the dividend demand that you talked about being in a position in Q4
to set a dividend strategy with a view to or having a view on the strategic footprint of the
group, but you also mentioned these strategic decisions will be taken over time. I think
you mentioned long term a few times in your comments. So I'm just trying to marry that
up. How can you be in a position to make a decision in Q4, given that your dividend
choices will depend on your strategic footprint of the group?
And my final question just really thinking about possible dissynergies from shrinking the
footprint of the group. Jason, perhaps you can remind us of the internal debt that remains
and where that sits, that might be one issue and there might be others as well that you
might care to mention at this stage? Thank you very much.

Bloomberg Transcript

A - Amanda Blanc

{BIO 19138679 <GO>}

Okay. Thank you, Blair. So in terms of why only GBP0.06? What we said in May, obviously,
was that we would come back in Q4 on all dividend matters. But as we discussed this at a
Board, we felt that it was important that we would pay something at this point to
recognize the importance of dividend to our shareholders and particularly in this difficult
economic environment, but obviously we have to balance that with prudence. We felt it
was -- fairly it was right to pay something, but we will come back on all other matters in
Q4.
As you said about the strategic footprint, I think again to go back to something I said
earlier on the dividend policy. The strategic footprint will be one part of the dividend
policy as well; our strategic priorities, the ongoing commitment to debt reduction, the
desire for a resilient and a sustainable dividend, so I think all of these things will be taken
in the round when we consider that policy.
But, Jason, on the dissynergies?

A - Jason Windsor

{BIO 17967688 <GO>}

Sure. I didn't quite -- I'll answer the specific question, Blair. On the internal debt, there's
only one upstream loan that's from the GI business of the group that is GBP7 billion,
dramatically reduced as part of the restructuring that we embarked on. And I remember it
well in 2013 when it was at GBP6 billion. So that has been fundamentally restructured over
the past seven years. I mean, otherwise, I don't see anything specific on other
dissynergies that you had in mind?

Q - Blair Stewart

{BIO 4191309 <GO>}

Page 15 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

So there is no other internal debt from group into the European subsidiaries, et cetera,
that's what I was thinking about?

A - Jason Windsor

{BIO 17967688 <GO>}

FINAL

I mean, there is downstream loans, maybe you'd expect that in the form -- and that's just
normal in a normal corporate finance. There is nothing else that you need to be aware of.

Q - Blair Stewart

{BIO 4191309 <GO>}

Okay, great. Sorry, Amanda, I forgot to just ask one question. Just on the deleveraging,
you've mentioned few times, the group's clearly got some deleveraging targets out
there. Just wondered if you -- if it's still stand or if you want to do more than that?

A - Amanda Blanc

{BIO 19138679 <GO>}

As I said, yes, we are committed to further debt reduction in the financial targets that we
have in place and still stand. We have GBP2.2 billion of maturities over the next two years,
so we believe there will be ample opportunity to reduce our debt.

Q - Blair Stewart

{BIO 4191309 <GO>}

Thank you.

Bloomberg Transcript

Operator
Your next question comes from the line of Fahad Changazi at Mediobanca. Please go
ahead. Your line is now open.

Q - Fahad Changazi

{BIO 15216120 <GO>}

Oh, hello. Good morning. Just two questions operationally, please, if I may. So, as you
said, there has been a strong performance in the bulk annuities in H1, given the attractive
pricing and the growth rate will moderate in H2. But has pricing come off now or can we
expect similar volumes in H2 versus H1, or will they be lower? And I suppose, given your
comments on being a leader in the UK, are -- will BPAs be a strategic focus, where we can
see Aviva increasing its market share?
And one more on Canada, strong combined ratio, a little help from reserve releases, but
in large part, the turnaround was to be driven by rates and given COVID considerations,
can you still put through more rates or will you get your target core when the full impact
the ratio already put through comes through? Thank you.

A - Amanda Blanc

{BIO 19138679 <GO>}

Okay. Thanks, Fahad. I'll pick up the question on the -- on BPAs and the leader in the UK,
and then Jason will pick up the other two points. So I think we do see the BPA market as
attractive for Aviva. We are number three in that market. It's the large, it's a compelling
market and clearly there is a structural growth opportunity there as companies seek to
derisk that pension liabilities. And I think combine that with the skills and capabilities that
Page 16 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

we have in that area and we do see that as a continued growth area. Jason, in terms of
the other two points?

FINAL

A - Jason Windsor

{BIO 17967688 <GO>}

Sure. So in BPA, growth in the first half was strong. I think last year we wrote just over
GBP4 billion, in the first half last year we wrote GBP1 billion, so you won't see that level of
growth and its a 2.5 times as I said in the second half, because we wrote GBP3 billion in
the second half last year. But the GBP4 billion gives you a sense of -- and we will clearly be
higher than that. We've got GBP1 billion scheme, where we are preferred provider on in
July. So we're already at last year's volume. So in the second half, we can be a bit more
selective. I think we will continue and allocate capital very carefully in BPA and we felt, as I
said a moment ago, we got really clear economic metrics driving all new business pricing,
but particularly in BPA given its scale. We're very clear the level of returns that we can
make and we will continue to be very watchful of that as we look forward, both in terms of
the price and the amount of capital that we allocate to. And you will see in the numbers,
the strain in the first half was actually really very attractive and that's obviously a direct
corollary of the pricing.

Bloomberg Transcript

In terms of Canada, I think it's unlikely that personal lines rate rises will be going through
any further. I think we did have significant filings across that, there was very large claims
inflation in '17 and '18. I think we sort of up with events, if you like. There will be some
pressure from politicians. There are always is in Canada to back out some of that rate
increase. But the underlying performance in Canada is really strong across the board. The
work that the guys have done in the last couple of years to turn that business around is
excellent. It's a good platform always to continue to grow.

Q - Fahad Changazi

{BIO 15216120 <GO>}

Okay. Thanks very much.

Operator
Our next is from the line of Colm Kelly with UBS. Please go ahead. Your line is open.

Q - Colm Kelly

{BIO 19140684 <GO>}

Hi, thanks; and good morning, everyone. And just a question on the review of the
dividend policy. So I know previous management were quite quick to reassure regarding
the dividend policy and the sustainability driven by the strong financials, as well as those
strong financials remain on show at half year despite volatility and derisking has been
enhanced. So has anything specifically changed on these financials or your view of them to
require the review of the dividend policy? That's the first question.
Secondly on the strategy and thanks a lot for providing the update on that today. Is there
anything you can say regarding your expectations for the mix, the business mix between
life, P&C and asset management that you would like to achieve over the medium term?

Page 17 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

And then, thirdly, a question on the return on capital for the group, as you know, it
currently benefits a lot from diversification in its capital base, which is a core part of the
return on capital that the group generates. With the update in the strategy for the
international business, are you confident that if those businesses are not part of the
group over the medium term and it wouldn't adversely impact on that diversification
benefits to the extent that it would then create a drag on the return on capital, which is a
core metric for the group? Thank you.

A - Amanda Blanc

{BIO 19138679 <GO>}

Thanks, Colm. So in terms, obviously, of your first question around the dividend policy and
there is a strong set of results. Obviously, I think if you just take, I guess, a step back, what
we've said today I think strategically is that there is a meaningful change to the focus of
the group and therefore with meaningful change, we believe it's also important that we
should review the dividend. So in the danger of repeating myself, but I will, if that's okay,
that will be set around the strategic priorities, the future shape of the group's portfolio,
the commitment to debt reduction and the desire for the dividend to be resilient and
sustainable. So that's the context upon which we will review the dividend policy.

Bloomberg Transcript

So as for strategy and the expectations around the balance between life, P&C and asset
management. I mean, we have more work to do clearly in that area and we -- and today
I'm not going to be talking to you about specific numbers. All I would say is that if I think -if I look at the way that customers look at insurers, they do not look at us as individual
business lines and, therefore, I think it's really important that. We have a good
diversification of products across those lines and so we can really enhance the strength of
the Aviva brand out to our customer base and that's really what we will be looking to do.
We already have very strong positions in many of our life product lines, GI product lines.
Again, I feel really boring if I know I'm repeating the same points, but i think it's really
important to stress. What we're saying is, we need to turn that -- those leading market
positions into leading market performance.
Jason, on the return on capital diversification question?

A - Jason Windsor

{BIO 17967688 <GO>}

Sure. Diversification comes in many forms within the group, within the big legal entities,
we have strong diversification by designs and we have multiple products, the UK-based
obviously between annuities and protection, but it's very different types of savings and
annuities. So that actual level of -- that is real value in having a mix product within both the
life and the core non-life subsidiaries. As you think about diversification between entities,
the predominant diversification benefit comes between the UK Life business, which is our
biggest business by quite a margin and the general insurance businesses in the UK and
Canada, but that's where we see the majority of it. There is clearly some internationally.
But then it tends to be slightly less, because that does correlate more with the market
risks that we have in the UK.

Q - Colm Kelly

{BIO 19140684 <GO>}
Page 18 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

Okay. Thanks a lot. Appreciate that.

A - Amanda Blanc

{BIO 19138679 <GO>}

FINAL

Thank you, Colm.

Operator
Next comes from the line of Andrew Crean at Autonomous. Please go ahead. Your line is
open.

Q - Andrew Crean

{BIO 16513202 <GO>}

Good morning, everyone.

A - Amanda Blanc

{BIO 19138679 <GO>}

Good morning, Andrew.

Q - Andrew Crean

{BIO 16513202 <GO>}

Bloomberg Transcript

A couple of three questions. Firstly, if you focus on UK, Ireland and Canada, UK Life is 80%
of that and in November last year, slide was presented saying that the cash generation
from UK Life would be flat over the next decade. Does that not set the scene for the
potential growth rate of the overall business in the long term, unless you can accelerate
UK Life?
The second question was a little bit of mean question, but we have had a number of
Chief Executives here at Aviva who've talked about being better and more efficient and
trying harder with greater focus and more operational efficiency. Could you give us a little
bit more detail below the line as to how you will be delivering these things different from
what was going on before? And whether you will be doing so with a different number of
lieutenants driving your businesses, or with the same people?
And then, finally, on the debt reduction, are we to assume that you will leave it all now
until the last year in 2022 or will you look in 2021, you've got some debt redemptions, I
think, in next year? Thank you.

A - Amanda Blanc

{BIO 19138679 <GO>}

Okay. Thank you, Andrew. So maybe I should start with your main question first, which was
the second one. So, look, I think, as I think I said and I think as you said earlier this week,
talking is the easy big, right? And so we know that. We know that we have to improve the
performance and -- but you also appreciate that we've always -- we also have to lay out
our plans to you guys and what will be different? Well, firstly, I think what will be different is
the context in which we set the strategy.
We set the strategy that we will be clearly focused on the markets where we believe we
can win and where we believe we can't win, we will manage for the long-term shareholder
Page 19 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

value. So that in itself creates an extra element of discipline and focus within the
organization, which means that when we have GBP1.3 billion to invest, we are very, very
clear about where that investment goes.
Now, the investment is one thing, but how we actually then deliver that is another. And
that will be around -- the week of around -- these things may sound a sort of obvious, but
execution is better than strategy. I have always, always said that. And the vigor and
discipline with which we follow through on where we've invested something, how we
achieve the benefits that we said it would, whether it's an efficiency benefit or whether it's
around the financial and the balance sheet. These are all areas where we will be
monitoring closely in making sure that we deliver on that.

Bloomberg Transcript

As 32 years experienced in working in insurance, the last sort of 15 as a CEO, I sort of
know, I think, what good looks like and I'm very focused on performance management
and you have to judge me by my actions. I don't expect that to happen today. Progress
needs to be made and we will come back to when we make progress, and we'll talk less
and act more. But all I can say today is, I am confident with what I have seen so far here
that we have the capability to be able to deliver what we say we're going to do. But as I
say, you have to judge us by our actions, not by our words.
In terms of the UK Life being a significant part of that business, of course it is. But also the
cash generation that comes from the back book, the cash flow, is a very, very important
part of how we invest and how we can grow the other areas of the business. We are
seeing good growth in areas -- in these areas around workplace. We've seen fund closing
US [ph] area over the last period and we've seen good growth in coms [ph] area around
commercial lines, the BPA growth is good. So what we have to look at is, what are the
insurance company of the future going to look like, where is the growth of the insurance
company of the future down going to look like, and we have to align ourselves to that. So
recognizing, I guess, we are in a good position and we have a strong back book and cash
flow coming through from that to help us to do that.
Jason, on the debt reduction?

A - Jason Windsor

{BIO 17967688 <GO>}

Sure. I mean, just on the cash flow, just to expand a little bit, if I may. The UK Life as we
presented it back in November was excluding the Savings and Retirement and Aviva
Investors business. So what we were trying to say is that we know there were certain
return part of about 20% of that book is that what we call heritages and runoff, but within
that we can grow and sustain that cash flow and that is the bedrock of the dividend paying
capability of the organization and it's a very stable cash flow, stock of cash flows within UK
Life.
On top of that is the growth potential in the investment and savings business. As you can
see today, we've made a good headway, continuing to grow there. We did really well in
workplace and retail savings and that's starting to hit the bottom line. And we've got real
operational leverage within those two segments. They are starting to really take hold. But

Page 20 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

I'm pretty confident about the outlook that we can have in terms of dividends and profit
growth within S&R.
In terms of debt reduction, look, we made some headway, but not as much yet on the
GBP1.5 billion reduction. The leverage ratio is 32%, right? So, our core metric that we
managed to get below the 30%, that was the GBP1.5 billion that we scaled previously, but
values held up well. We do have some redemptions in 2021, as you mentioned, I think in a
reasonably significant and significant again in 2022. So we've got some flexibility. I think at
this stage, we remain committed to that lower leverage as we've mentioned, I think, twice
on the front page of the press release. So we are committed to that. The timing of which I
think we will be reviewing again when we think about strategy and dividends, but we're
certainly hoping to make progress in 2021.

Q - Andrew Crean

{BIO 16513202 <GO>}

Okay. Thanks.

Operator
Next comes from the line of Gordon Aitken, RBC. Please go ahead. Your line is open.

Bloomberg Transcript

Q - Gordon Aitken

{BIO 3846728 <GO>}

Good morning. Thanks. And first question is on disposals. It's very difficult to dispose of
businesses when you can't meet people face to face, unless, of course, already have
relationships with potential buyers. So are there regions or countries where these
relationships are -- already exist, so that COVID won't be too much of a barrier?
And second question is on the proceeds you might get. I mean you've talked about the
options of investing in businesses or returning capital to shareholders, just on the former,
are you talking about acquisitions or are you talking about, say, writing more new business.
And then finally on bulk annuities. Can you share the view of your predecessors have had
that the large end of the market is not as attractive as the smaller end? Thanks.

A - Amanda Blanc

{BIO 19138679 <GO>}

Okay. Thank you, Gordon. And so, again, just to restate, we haven't spoken about
disposals today. What we've said is this is the way that I'm viewing the portfolio and we
need to look at the businesses in the international area and ensure that they are
delivering the right returns for us and whether that would be around cash, around the
return on capital, those are all the areas that we will look at.
And the fact that we can't meet people face to face, I don't think there is not that sense
of urgency, I've said longer-term shareholder value. And -- but in many respects, the world
have adapted brilliantly, hasn't it, and to this new way of working and I think if we just said
six months ago that we would be working in the way that we are working today, remotely,
I think we've been pretty successful of that.

Page 21 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

FINAL

On the proceeds, again, just to be clear, today is not the day to talk about acquisitions.
Investment in the business, investing for growth that will be centered around the
businesses that we've said in our -- in the UK, Ireland and Canada. And those businesses
already have a significant amount of investment certified for them. What we need to do,
and I'm very boring, I know I'm going to say again, is make sure that the money that we're
investing is delivering the benefit that we expect and that is where we will be focused.
In terms of the footprint on BPA --

A - Jason Windsor

{BIO 17967688 <GO>}

BPA, sure, I think we've been spreading our wings slowly over the last three or four years.
We continue represent, as I said earlier, a big scheme already in July, which is a GBP1
billion just around, we did a big scheme earlier in the year of approximately GBP1 billion.
We wrote a big scheme last year. I think we still prefer and it will be bit around that level or
smaller. It just easier from a balance sheet management perspective on the assets and
the reinsurance and the like, where we have, as I said, so to spread our wings and starting
to get more comfortable with the way that we can risk manage those particular
transactions.

Q - Gordon Aitken

{BIO 3846728 <GO>}

Thank you.

Bloomberg Transcript

Operator
Next question comes from the line of Dom O'Mahony at Exane BNP Paribas. Please go
ahead. Your line is open.

Q - Dominic O'Mahony
Hello, folks, and thank you for taking the questions. And firstly, Amanda, congratulations
on the new job.

A - Amanda Blanc

{BIO 19138679 <GO>}

Thank you.

Q - Dominic O'Mahony
So two questions. I guess, first is, on the perimeter, you've been very, very clear about the
focus being on UK, Ireland and Canada, the business is being managed for sort of
manage the value. There was some discussion in the investment community about
whether Aviva is the right holder the heritage book in the UK, whether that might be -- it's
been a bit to supporting that? Should we be reading the focus on the geography as a sort
of a statement adaption not a priority or that's really not a likely outcome?
And then second question and sort of hobble around the dividend and looking forward
for Q4 update. But everything you've said in terms of financials suggests that the
financials of the business with the current perimeter are not preventing you from
Page 22 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

maintaining the dividend at the level it was, say, last year. I just wanted to confirm, in
particular, relatively recently you gave us some targets for cash and capital generation,
but assuming that the perimeter doesn't change, is there any reason for those cash and
capital targets to be lower than you previously talked? Thank you.

FINAL

A - Amanda Blanc

{BIO 19138679 <GO>}

Okay. Thank you. So on the perimeter and your question around heritage and what we do
with that. So I think, firstly, let's make the statement, we're committed to being the UK
driven insurer, therefore we're committed to being composite. And the UK back book
generate, as Jason, I think, just alluded to, a significant amount of cash flow and we
believe that it is important to our financial strength and balance sheet resilience. And so
that hopefully clarifies that point, but just to reinforce our commitment to the composite.
As far as the targets are concerned, I think, we're saying today quite clearly that we're not
announcing any changes to the targets today. But as Jason outlined, COVID-19 has made
achieving some of those targets a little more difficult. But the dividend policy review will
be set in the context of the meaningful change that we have spoken about today on the - what way we look at the portfolio, the strategic priorities of the group, our commitment
to debt reduction. I know I'm repeating myself, but I'm (multiple speakers)

A - Jason Windsor

{BIO 17967688 <GO>}

Bloomberg Transcript

(multiple speakers) no one has changed my targets or any of the other management
teams.

A - Amanda Blanc

{BIO 19138679 <GO>}

Absolutely.

A - Jason Windsor

{BIO 17967688 <GO>}

We are after them, right, and we've got no room to maneuver. As I said at the Q1 call, that
is going to be harder to achieve, that's of life, we're going to take that and try down this
to make sure that we got there.

Q - Dominic O'Mahony
Very clear. Thank you so much.

Operator
Your next question comes from the line of Abid Hussain at Credit Suisse. Please go
ahead. Your line is open.

Q - Abid Hussain

{BIO 20229932 <GO>}

Hi. Good morning, all. Thanks for taking my questions.

Page 23 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

A - Amanda Blanc

{BIO 19138679 <GO>}

Good morning.

FINAL

Q - Abid Hussain

{BIO 20229932 <GO>}

Good morning. I've got two questions remaining, I think. Firstly, just coming back to the
remittances, I just wanted to check if there were any minimum capital hurdles that you
came up against -- within the local entities that prevented you from taking out the cash? It
sounds like, there wasn't. And if that was the case, was it just a case of a soft request
from the regulators, so just any more color on that would be helpful?
And on the second question, I'm afraid perhaps coming back to the difficult question that
Andrew asked on portfolio exits. I guess the question is really -- if you can remind us, what
options have already been looked at on the portfolio exits on the international businesses
in the past and what is different in the way that you're approaching these businesses?
Also, there was a slight concern. We've been there before. I think that's what some of us
are concerned about, especially if you're saying sort of you want to manage these
international businesses for long-term value. So it's difficult to kind of decide what side
you are landing on this? So you're just landing on the side that you want to dispose of
these businesses? Or five years down the line, you still have the same perimeter?

Bloomberg Transcript

A - Amanda Blanc

{BIO 19138679 <GO>}

Okay. Thank you. I'll pick up that and hand to Jason on the remittances. So what we've
said -- I'm not going to comment on the previous reviews on portfolios and exits through
what we've considered and what we haven't considered and I don't genuinely think that
you would expect me to do that anyway and you're concerned about having been here
before again and danger of repeating myself, I get that.
But what we've done here, I think and I don't think this has been done before is we've
been very clear and we are very transparent and honest about how we view the portfolio
going forward. And we very much view the portfolio in terms of the businesses where we
will invest for growth, the UK, Ireland and Canada, and the businesses where we will
manage for long-term shareholder value. And that does put us -- is different, I think, from
the past, because that does put a different lens on how you invest and how you see
those businesses and actions that you take on a day-to-day basis and I think that -- you will
-- we will come back to you as we have more to say when we make more tangible
progress.
Jason, on the remittances?

A - Jason Windsor

{BIO 17967688 <GO>}

Sure. We chose somewhat out of discretion not to take dividends in the first half. Clearly
there were challenges around the amplitude that the market moves in the early part of
the crisis and that just not the right time to be thinking about dividends, we're thinking
about many other things around supporting customers and stabilizing the balance sheet.
The group has got very strong liquidity and treasury as we continue to announce. So there
was no shortage of cash around the place. So that's the overriding concern. Clearly it's
Page 24 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

been specific as I said a minute ago, the multilateral and national supervisory comments
on dividends, particularly out of Europe, the cognizance of those. And as I've said on a
couple of these calls, we listened intently to the views of our regulators and we continue
to build relationships with them.

FINAL

A - Amanda Blanc

{BIO 19138679 <GO>}

Thank you.

Q - Abid Hussain

{BIO 20229932 <GO>}

Thank you.

Operator
Next question comes from the line of Oliver Steel at Deutsche Bank. Please go ahead.
Your line is open.

Q - Oliver Steel

{BIO 6068696 <GO>}

Bloomberg Transcript

Good morning, and three questions. We're all very much looking forward to the fourth
quarter update, by the way, because most of today's questions haven't really been
answered.
And the first is, nine months ago, the Board of Aviva came up with a rather different
strategy and I know that was before your time, but you must be very well aware of the -of how the decision making process has changed during that period. So I'm wondering
what is it in the Board's mind that has actually shifted you from the strategy under your
predecessor to the new one?
And secondly and at rather more parochial level and any plans to the management
actions in the second half or guidance that you want to give on that?\
And then, thirdly, does possible disposals or certainly a sort of lower emphasis on the
international operations change the local capital levels that are required in those local
operations either for there better or worse?

A - Amanda Blanc

{BIO 19138679 <GO>}

Okay. Thank you, Oliver, and apologies if you think we've not been answering certain
questions.
And so in terms of the way that the Board saw the strategy nine months ago, as you quite
rightly said, I wasn't on the Board nine months ago, so I really can't comment on that. I was
actually in -- on the Board since the start of this year and I have been part of the very
fulsome and good debates that we've had on strategy and this is the strategy that the
Board is fully committed to. We have a new Chair and we have a number of new Board
Members and we've had a good debate about the strategy and we are all fully behind
and committed to delivering on this strategy and I think we've been clear, we've been
Page 25 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

very, very clear about what we will focus on and how we will take that -- and how we will
update you as we go forward.

FINAL

Jason, would you like to pick up the two points on management actions and the lower
emphasis on capital?

A - Jason Windsor

{BIO 17967688 <GO>}

Yeah. On management action, I think from an IFRS perspective, we hit, I think, GBP69
million in the first half -- I'd given guidance in the past, it's about GBP200 million [ph], but I
don't think I will go back. It might be up slightly. We're not expecting anything like the level
of release that we have in 2019 or 2018, just to be clear. I think I was clear on that back in
November. I just reiterate that guidance somewhere in that 0 [ph] to GBP200 million [ph]
range as our long-term expectation for IFRS and we said slightly higher for OCG,
somewhere up GBP200 million north of run rate there and then there is contribution on
the SCR side.
On local capital levels, I mean I honestly don't know. We thought about that a little bit. This
is the way that regulators are reacting to COVID-19 in more broadly. We're exiting a
Solvency II framework that has actually behaved pretty well. Obviously some refinements
many of us talked about, but if we find to that framework, we believe in economic capital,
we managed to it and we think -- I think it's worked well for us and I don't see any
consequences of the capital management as a consequence of what Amanda said today.

Bloomberg Transcript

Q - Oliver Steel

{BIO 6068696 <GO>}

Yeah. Sorry, just to follow up quickly on that. What I'm asking is, does it -- as a result of
your strategic announcement today, does that change the local regulatory? Does that
change any need for cash in most local subsidiaries?

Q - Jonathan Hocking
As you said, Oliver, I don't see any indirect consequence on capital in those subs.

Q - Oliver Steel

{BIO 6068696 <GO>}

Thank you.

A - Jason Windsor

{BIO 17967688 <GO>}

We're just giving a strategic update today. There is no -- there's nothing beyond that and
there is nothing beyond that for regulators to react to.

Q - Oliver Steel

{BIO 6068696 <GO>}

Thank you.

Operator
And that does conclude the Q&A session. I will hand the call back over to Amanda.
Page 26 of 27



Company N ame: Aviva PL C
Company Ticker: AV/ L N Equity
Date: 2020-08-06

A - Amanda Blanc

{BIO 19138679 <GO>}

FINAL

Okay. Thanks, Nicole, and thanks everyone for joining the call. And as we have I've
outlined today, I think we're reporting a solid second half year results. I'm really proud of
how people are going above and beyond to support customers during the crisis and I'm
going to thank them all for their hard work. I do -- I will say again, look forward to meeting
many of you virtually or hopefully in person in the coming weeks and months and sharing
our progress with you.
Thank you so much for listening, and I hope you all manage to get a break even if it's a
staycation over the summer holidays. Thank you very much.

Operator

Bloomberg Transcript

That does conclude the conference for today. Thank you for participating. You may all
disconnect.

This transcript may not be 100 percent accurate and may contain misspellings and other
inaccuracies. This transcript is provided "as is", without express or implied warranties of
any kind. Bloomberg retains all rights to this transcript and provides it solely for your
personal, non-commercial use. Bloomberg, its suppliers and third-party agents shall
have no liability for errors in this transcript or for lost profits, losses, or direct, indirect,
incidental, consequential, special or punitive damages in connection with the
furnishing, performance or use of such transcript. Neither the information nor any
opinion expressed in this transcript constitutes a solicitation of the purchase or sale of
securities or commodities. Any opinion expressed in the transcript does not necessarily
reflect the views of Bloomberg LP.  COPYRIGHT 2022, BLOOMBERG LP. All rights
reserved. Any reproduction, redistribution or retransmission is expressly prohibited.

Page 27 of 27

